| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Fusion Pharmaceuticals Inc. | Chief Medical Officer | Common Stock | 2,022 | $4,105 | $2.03 | 31 Aug 2021 | Direct |
| Fusion Pharmaceuticals Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 159,000 | 01 Feb 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000120919122007052-o-leary-james-j-2022-02-01 | Fusion Pharmaceuticals Inc. | 01 Feb 2022 | 2 | $0 | 4 | Chief Medical Officer | 03 Feb 2022, 18:38 |